Primary chemotherapy in breast invasive carcinoma: predictive value of the immunohistochemical detection of hormonal receptors, p53, c-erbB-2, MiB1, pS2 and GST pi. (Q36136174)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Primary chemotherapy in breast invasive carcinoma: predictive value of the immunohistochemical detection of hormonal receptors, p53, c-erbB-2, MiB1, pS2 and GST pi.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Primary chemotherapy in breast invasive carcinoma: predictive value of the immunohistochemical detection of hormonal receptors, p53, c-erbB-2, MiB1, pS2 and GST pi. (English)

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

1 reference

based on heuristic

inferred from title

invasive carcinoma

1 reference

based on heuristic

inferred from title

immunohistochemistry

1 reference

based on heuristic

inferred from title

author name string

G MacGrogan

1

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

L Mauriac

2

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

M Durand

3

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

F Bonichon

4

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

M Trojani

5

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

I de Mascarel

6

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

J M Coindre

7

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

language of work or name

0 references

publication date

1 November 1996

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

74

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

9

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

1458-1465

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Prognostic factors and response to therapy in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074756

2 October 2017

S-phase fraction and survival benefit from adjuvant chemotherapy or radiotherapy of breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074756

2 October 2017

The effects of chemotherapy on morphology, cellular proliferation, apoptosis and oncoprotein expression in primary breast carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074756

2 October 2017

Pathological assessment of response to induction chemotherapy in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074756

2 October 2017

Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074756

2 October 2017

Randomised trial of chemotherapy versus endocrine therapy in patients presenting with locally advanced breast cancer (a pilot study)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074756

2 October 2017

Cell kinetics and chemotherapy: a critical review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074756

2 October 2017

Statistical aspects of prognostic factor studies in oncology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074756

2 July 2018

Aggressive adriamycin-containing regimen (PM-FAC) in estrogen receptor-negative disseminated breast cancer. Results of a Southwest Oncology Group trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074756

2 July 2018

Differential increases in glutathione S-transferase activities in a range of multidrug-resistant human tumor cell lines.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074756

2 July 2018

Results of neoadjuvant chemotherapy and radiation therapy in the breast-conserving treatment of 250 patients with all stages of infiltrative breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074756

2 July 2018

Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Results of a randomized trial in a single centre

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074756

2 July 2018

HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074756

2 July 2018

Neoadjuvant chemotherapy in 126 operable breast cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074756

2 July 2018

Over-expression of P-glycoprotein and glutathione S-transferase pi in MCF-7 cells selected for vincristine resistance in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074756

2 July 2018

Human breast cancer: prognostic significance of the c-erbB-2 oncoprotein compared with epidermal growth factor receptor, DNA ploidy, and conventional pathologic features

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074756

2 July 2018

Low incidence of estrogen receptor in breast carcinomas with rapid rates of cellular replication

1 reference

https://pubmed.ncbi.nlm.nih.gov/8912545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of p53 in breast invasive ductal carcinoma: an immunohistochemical study on 942 cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/8912545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between proliferative activity and estrogen receptors in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8912545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential killing efficacy of twenty antitumor drugs on proliferating and nonproliferating human tumor cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/8912545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Breast cancer and response to chemotherapy: a possible relationship of hormone receptors and doxorubicin

1 reference

https://pubmed.ncbi.nlm.nih.gov/8912545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Progesterone receptor activity and relapse-free survival in patients with primary breast cancer: the role of adjuvant chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/8912545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in cell kinetics induced by primary chemotherapy in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8912545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sequential cytopunctures during preoperative chemotherapy for primary breast carcinoma. II. DNA flow cytometry changes during chemotherapy, tumor regression, and short-term follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/8912545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neoadjuvant chemotherapy in operable breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8912545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DNA flow cytometry and response to preoperative chemotherapy for primary breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8912545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of the S-phase fraction of breast cancers treated by primary radiotherapy or neoadjuvant chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/8912545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8912545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Conservative treatment feasibility with induction chemotherapy, surgery, and radiotherapy for patients with breast carcinoma larger than 3 cm

1 reference

https://pubmed.ncbi.nlm.nih.gov/8912545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8912545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship of variations in tumor cell kinetics induced by primary chemotherapy to tumor regression and prognosis in locally advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8912545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical determination of pS2 in invasive breast carcinomas: a study on 942 cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/8912545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prognostic value of c-erbB2 in primary breast carcinomas: A study on 942 cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/8912545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proliferation kinetics of a human breast cancer line in vitro following treatment with 17beta-estradiol and 1-beta-D-arabinofuranosylcytosine

1 reference

https://pubmed.ncbi.nlm.nih.gov/8912545

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.1996.565

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36136174&oldid=2198255709"